<strong>Package details</strong>: 28 tablets

<strong>Manufacturer</strong>: Astellas Pharma Inc., Japan

<strong>Active ingredient:</strong> enzalutamide (chemical formula C21H16F4N4O2S)

<strong>Medical effect</strong>: Xtandi tablets are effective for the treatment of castration-resistant prostate cancer and metastatic prostate cancer.